pSivida Corp. (PSDV) ,,,,, un GIOIELLO !!!

The 5th Annual Ophthalmic Drug Development and Delivery Summit
Emerging Scientific Innovations in Treating Ocular Diseases: Targets, Delivery and Regulatory Strategies
September 21st - 22nd, 2009
Hilton San Diego/Del Mar


Now in its fifth year, PEA’s Ophthalmic Drug Development and Delivery Summit will enlighten you about the latest developments regarding disease pathogenesis and novel targets for treatment of ocular diseases such as:

Retinopathies
Wet and dry AMD
Retinitis pigmentosa
DME/DR
Glaucoma
Ocular surface diseases
Inflammatory diseases of the eye

In addition to that, the summit also features a couple of sessions addressing the latest developments in the following areas:

Ocular Drug Delivery
Current expectations of regulatory agencies
Latest developments regarding animal models


We’d like to thank our expert speaking faculty:
Kay Rittenhouse, Ph.D., Pfizer Inc.
Rajendra Apte, MD, Ph.D., Washington University School of Medicine
Michael Swit, The Weinberg Group Inc.
David Eveleth, Ph.D., Pfizer Inc.
Remis Bistras, Ph.D., Eye Gate Pharmaceuticals
Joachim Kohn, Ph.D., Rutgers University
Gerard Lutty, Ph.D., Wilmer Ophthalmological Institute
P. Vasanth Rao, Ph.D., Duke University School of Medicine
Barbara Wirostko, MD, Pfizer Inc.
Devin Welty, Ph.D., Allergan Inc.
Paul Ashton, Psivida Ltd.
Ashim Mitra, Ph.D., University of Missouri
Gary Novack, Ph.D., Pharma-Logic Development, Inc.
Konrad Kauper, Neurotech Pharmaceuticals
 
NEW YORK, Sept. 21 /PRNewswire/ -- New York Investors Council (NYIC) is
pleased to announce its First Annual New York Micro-Cap Conference. Please
visit http://www.nyinvestorscouncil.com and register now to join the New York
Investors Council at its First Annual New York Micro-Cap Conference, starting
8 am, Monday, January 11, 2010 at the Grand Hyatt in midtown Manhattan.


"We expect approximately 100 companies representing a wide array of industry
sectors to present at the Conference," stated Peter D'Agostino, Director of
Corporate Access at NYIC.

Attendees will have access to all 45-minute presentations and one-on-one
meetings with senior management. This enlightening one-day event is sure to
help investors discover new and valuable micro-cap companies and
opportunities. Few of the presenting companies are well-followed, and pink
sheet companies will not be among the presenters. The intriguing stories
being showcased are all underpinned by solid fundamentals or unique growth
catalysts.

The Conference is sponsored by a variety of well-regarded companies, including
CSCA Capital Advisors, LLC, Hawk Associates, Inc., SeekingAlpha, Sidoti & Co.,
LLC, PR Newswire and Vintage Filings. The goal is to have this conference
regarded as the micro-cap event of the year!

Among the presenters registered to participate:

*Baldwin Technology Co., Inc. (BLD) *Bitstream Inc. (BITS)
*Bofi Holding Inc. (BOFI) *Computer Task Group Inc. (CTGX)
*Integrated Vision Inc. (INVI) *Kolicke & Soffa Industries Inc.
(KLIC)
*Lionbridge Technologies Inc. (LIOX) *Mattson Technology Inc. (MTSN)
*Neogenomics Inc. (NGNM) *Lydall Inc (LDL)
*Providence Service Corp. (PRSC) *Provectus Pharmaceuticals Inc.
(PVCT)
*pSivida Corp. (PSDV) *Tri-Isthmus Group, Inc. (TISG)
*Uni-Pixel Inc. (UNXL) *Uranium Energy Corp (UEC)
*WidePoint Corp. (WYY)


Investors, analysts, venture capitalists, media and others within the
financial investment community are all encouraged to participate in this
exciting and informative investor conference. For more information, please
call the NYIC at 212.542.4000 or register at
http://www.nyinvestorscouncil.com.

About New York Investors Council
New York Investors Council seeks to improve on the lack of visibility for
companies with small market capitalizations. The current lack of visibility is
creating greater and greater market inefficiencies, and our mission is to
address the increasing demand for a forum that provides investors unmatched
access to managers of leading micro-cap companies.
 

Users who are viewing this thread

Back
Alto